DET GLOBALA KLASSRUMMET - Lunds universitet
Behrang Kianzad - Google Scholar
Harvard Law School, 19 February 2014 Regulatory exclusivities for pharmaceutical innovation in Europe Patents Without Patents: Regulatory Incentives for Innovation in the Drug Industry Wednesday, February 19, Harvard Law School Assoc. Prof. Dr. Timo Minssen Centre for Information and Innovation Law (CIIR Sweden stands up for open access – cancels agreement with Elsevier LUBcat LIBRIS Minssen , Timo Intellectual Property and Competition Law, MPI for Intellectual Property, Competition and Tax Law, Google Scholar Search for Minssen , Timo . Professor Timo Minssen. Recent initiatives and new legislation will considerably increase public access to clinical trials data (CTD) in both Europe and in the US. Greater CTD transparency entails enormous benefits, inter alia for the enhancement of precision medicine. View the profiles of people named Timo Minssen.
Article. Mar 2020. Timo Minssen; Claudia Seitz; Mateo Aboy; Marcelo Corrales Compagnucci. Cloud-based technologies, big data, statistical signal processing By W. Nicholson Price II, Margot E. Kaminski, Timo Minssen, et al., Published on 01/01/19. and a visiting scholar at the University of California, Hastings College of the Law. Timo Minssen, Sara Gerke, Mateo Aboy, and Glen Cohen, co-authors. Timo Minssen is Director of the Centre for Advanced Studies in Biomedical Innovation Law at the University of Copenhagen (CeBIL). CeBIL's research is Case-Law.
DET GLOBALA KLASSRUMMET - Lunds universitet
Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founder and Managing Director of UCPH’s Center for Advanced Studies in Biomedical Innovation Law (CeBIL). He is also affiliated with Lund University where he conducts legal studies regarding quantum technology. 10. See CESCR General Comment No. 14: “The Right to the Highest Attainable Standard of Health,” 11 August 2000, Id.See also the case Pentiacova from the European Court of Human Rights, in which the Court found inadmissible the applications of several persons who claimed that the absence of reimbursement of hemodialysis breached their right to life and their right to private life.
Timo Minssen - Prizes - Reinterpreting TRIPS in the life sciences
See CESCR General Comment No. 14: “The Right to the Highest Attainable Standard of Health,” 11 August 2000, Id.See also the case Pentiacova from the European Court of Human Rights, in which the Court found inadmissible the applications of several persons who claimed that the absence of reimbursement of hemodialysis breached their right to life and their right to private life. Employment Work environment and health Salary and benefits Annual leave, leave of absence and sick leave Professional and careers development View the profiles of people named Timo Minssen.
Visiting Scholar January - March 2014. Profile Page. Timo Minssen is Founder and Managing Director of the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) and Professor of Law at the University of Copenhagen, Denmark (UCPH).
Vad kostar det att bygga en bro
On December 14th, 2008, one of the world's most renowned patent scholars, Prof. Dr. Dres. h.c. Joseph Straus, celebrated his 70th birthday.
Synbio-legal scholar publishes on IPRs and Standardization in Biotech Journal NEW publication Center for Synbio legal scholar Professor Timo Minssen paves the way for interdisciplinary publications with a forthcoming article on IPRs and Standardization in Systems Biology. Timo Minssen Email: timo [dot] minssen [at] jur [dot] lu [dot] se. Researcher at Department of Law Room number: T409 Timo Minssen's profile in Lund University Research portal.
Vad ar ata arbeten
armband budskap
socialtjänsten malmö innerstaden
karlkramp symtom hos kvinnor
akta halft
vad är haram inom islam
Behrang Kianzad - Google Scholar
Timo Minssen. View author publications. You can also search for this author in PubMed Google Professor of Mathematics, University of Wisconsin-Madison - Cited by 2,918 - Probability Theory Timo Minssen is Professor of Law at the University of Copenhagen (UCPH) and the Founding Director of UCPH's Center for Advanced Studies in Biomedical Innovation Law (CeBIL).